ROBERT GARRIGUS: Open Payments
NPI 1578910584 · MAITLAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,563 in 66 payments from 14 companies in 2025. Trend: 2023 $1,398 · 2024 $2,051 · 2025 $1,563
Food & beverage: $1,458Education: $105
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $546 |
| Regeneron Healthcare Solutions, Inc. | 7 | $280 |
| Janssen Biotech, Inc. | 11 | $207 |
| LEO Pharma Inc. | 4 | $84 |
| PFIZER INC. | 5 | $80 |
| GENZYME CORPORATION | 2 | $65 |
| Galderma Laboratories, L.P. | 2 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| Organon LLC | 2 | $49 |
| Amgen Inc. | 2 | $48 |
Products named: DUPIXENT, RINVOQ, SKYRIZI, TREMFYA, CIBINQO, NEMLUVIO, OTEZLA, ANZUPGO.
Industry payments across FL — which companies pay providers there.
